REACTOME Pathway ID | Description |
---|
5953415 | Adaptive Immune System |
5953413 | Antigen activates B Cell Receptor (BCR) leading to generation of second messengers |
5954570 | Constitutive PI3K/AKT Signaling in Cancer |
5953536 | Cytokine Signaling in Immune system |
5953408 | DAP12 interactions |
5953407 | DAP12 signaling |
5953253 | Disease |
5953994 | Downstream signaling events of B Cell Receptor (BCR) |
5953399 | Downstream signaling of activated FGFR |
5953396 | Downstream signal transduction |
5953417 | Fc epsilon receptor (FCERI) signaling |
5953884 | GAB1 signalosome |
5953410 | Immune System |
5953409 | Innate Immune System |
5953534 | Interleukin-2 signaling |
5954001 | Interleukin-3, 5 and GM-CSF signaling |
5954000 | Interleukin receptor SHC signaling |
5953250 | Metabolism |
5953289 | Metabolism of lipids and lipoproteins |
5953394 | NGF signalling via TRKA from the plasma membrane |
5953474 | Phospholipid metabolism |
5953989 | PI3K/AKT activation |
5953997 | PI3K/AKT Signaling in Cancer |
5953885 | PI-3K cascade |
5953996 | PI3K events in ERBB2 signaling |
5953995 | PI3K events in ERBB4 signaling |
5954478 | PI Metabolism |
5953993 | PIP3 activates AKT signaling |
5954358 | Regulation of signaling by CBL |
5953998 | Role of LAT2/NTAL/LAB on calcium mobilization |
5953403 | Signaling by EGFR |
5953404 | Signaling by EGFR in Cancer |
5953406 | Signaling by ERBB2 |
5953540 | Signaling by ERBB4 |
5953400 | Signaling by FGFR |
5953401 | Signaling by FGFR in disease |
5953535 | Signaling by Interleukins |
5953397 | Signaling by PDGF |
5953541 | Signaling by SCF-KIT |
5953414 | Signaling by the B Cell Receptor (BCR) |
5953395 | Signalling by NGF |
5953381 | Signal Transduction |
5954499 | Synthesis of PIPs at the plasma membrane |